Restasis MultiDose
NDC 0023-5301, cyclosporine, emulsion, from Allergan, Inc..
- Product NDC
- 0023-5301
- Status
- Listed
- Labeler
- Allergan, Inc.
- Dosage form
- EMULSION
- Route
- OPHTHALMIC
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA050790
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0023-5301 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYCLOSPORINE.5 mg/mL
Pharmacologic classes
Calcineurin Inhibitor Immunosuppressant [EPC]; Calcineurin Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0023-5301-05 | 00023530105 | 1 BOTTLE in 1 CARTON (0023-5301-05) / 5.5 mL in 1 BOTTLE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/7224d810-bb96-4682-a942-3355e6e8061aNADAC price for package 00023530105
GET /v1/drugs/nadac/00023530105
Use it
Look up 0023-5301 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0023-5301 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0023-5301. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.